Clinical trial

Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia

NCT01662648

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-06-01

PhasePHASE3

Study timeline

Study start (unknown)2007-06-01Date precision: month

Registry last updated2014-05-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Paliperidone ERDRUG

Sponsors & collaborators

Janssen Pharmaceuticalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01662648 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.